Developer docs
API playgroundTry for free, no card

Search company profiles

The March Group

Full company profile

uuid0003hrg

Namestring
The March Group
Legal namestring
March Partners LLC
Websiteurl
marchgp.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

The March Group (legal entity: March Partners LLC, incorporated in Delaware) is a thematic early-stage venture capital firm founded in 2019 and headquartered in Sacramento and Davis, California, with a stated mission of identifying and scaling exponential technologies at the intersection of food, health, and life sciences. The firm structures its investing around three thematic verticals — Precision Nutrition, Intelligent Health, and Food & Medicine — and codifies an "AI-at-the-Center" thesis that links artificial intelligence to GLP-1-driven disruption of the food industry. TMG operates two principal fund vehicles: the Aggie Venture Accelerator Fund, a pre-seed vehicle targeting UC Davis and UC system spinouts (offering up to $250,000 per startup through the April 2026-launched Aggie Venture Accelerator), and March EXP, the flagship early-stage fund backing category leaders across the three verticals. The portfolio includes ZeroAvia (hydrogen-electric aviation), Meati Foods (mycelium protein), Rivalz (AI-powered nutrition), Digestiva (food biotech enzymes), Engage3 (retail price intelligence), EvodiaBio (precision fermentation aromas), Number 8 Bio (methane-reducing feed additives), and VinZymes.

The firm monetizes primarily through venture fund management — management fees and carried interest on portfolio exits — with a secondary revenue stream from strategic advisory services for institutional partners such as the Bill & Melinda Gates Foundation. TMG serves two customer layers: (1) portfolio companies, which receive capital, mentorship, structured programming through the Aggie Accelerator, and access to AI tooling via partner PIPA; and (2) institutional advisory clients, most notably the Gates Foundation's Accelerator team, which TMG supports on advanced technology integration into the global food system. Deal flow is sourced primarily through TMG's anchor partnership with the UC Davis Innovation and Economic Development Office, broader UC system access (~1,400+ UC-formed startups, 250+ UC-linked $1B+ companies), and a strategic global network that includes the Novo Nordisk Foundation's BioInnovation Institute, HKUST, Lawrence Livermore National Laboratory, and the National Academies. TMG is led by four partners — Founding Partner Dr. Harold Schmitz (former Chief Science Officer of Mars, Incorporated), Christopher Lai, Stephen Badger, and Dr. Tony Lau — and operates as an independent, privately-held firm with no parent company or disclosed institutional investors in the firm itself.

Short descriptiontext

The March Group is a thematic early-stage venture capital firm that invests in exponential technology platforms across Precision Nutrition, Intelligent Health, and Food & Medicine, serving portfolio companies through pre-seed (Aggie Venture Accelerator Fund) and flagship (March EXP) vehicles while anchored within the UC system and advising institutional partners such as the Gates Foundation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDavis, United States
HQ citystring
Davis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital, early-stage investing, life sciences investment, food tech venture, thematic venture capital
Industry4 codes
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYFSANAHAD
Corporate Accelerators & Startup Programs
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Early-Stage Investment Management
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Venture Capital Fund Management
TypeLicensing Royalties
Description

TMG manages venture funds including the Aggie Venture Accelerator Fund (pre-seed investments) and March EXP (flagship early-stage venture fund). Revenue generated through management fees and carried interest on portfolio company exits.

marchgp.com
2Strategic Advisory Services
TypeProfessional Services
Description

TMG provides strategic advisory services to institutional partners such as the Bill & Melinda Gates Foundation, supporting their Accelerator team's initiatives focused on advanced technologies and global food system improvements.

marchgp.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The March Group is a thematic early-stage venture capital firm that invests in and supports exponential technology platforms at the intersection of food, health, and life sciences. The firm manages the Aggie Venture Accelerator Fund (pre-seed investments in UC Davis and UC system spinouts) and March EXP (flagship early-stage fund) targeting category leaders in Precision Nutrition, Intelligent Health, and Food & Medicine. TMG also provides strategic advisory services to institutional partners such as the Bill & Melinda Gates Foundation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 300 UC Davis-supported startups have raised over $4 billion in funding over the past decade
+1 more record
Product overview1 text field

The March Group (TMG) is a thematic early-stage venture capital firm that operates two primary investment vehicles: the Aggie Venture Accelerator Fund and March EXP. The Aggie Venture Accelerator Fund is a pre-seed fund focused on identifying spinouts and translational ventures from UC Davis and the UC system. March EXP is TMG's flagship early-stage venture fund targeting category leaders in Precision Nutrition, Intelligent Health, and Food & Medicine. TMG's portfolio includes investments in companies such as Engage3, Digestiva, Rivalz, ZeroAvia, VinZymes, EvodiaBio, Number8Bio, and Meati Foods.

Product and service2 records
1Aggie Venture Accelerator Fund
CategoryInvestment Fund
Description

A pre-seed fund managed by The March Group that seeks to identify the best spinouts and translational ventures emerging from UC Davis and the broader UC system. It is part of the Aggie Venture Accelerator program offering mentorship, structured programming, and investment to early-stage startups at the intersection of life science, food, and health.

2March EXP
CategoryInvestment Fund
Description

The flagship early-stage venture fund of The March Group that invests in category leaders emerging in Precision Nutrition, Intelligent Health, and Food & Medicine. Portfolio companies include ZeroAvia, Meati Foods, Rivalz, Digestiva, EvodiaBio, Number 8 Bio, Engage3, and VinZymes.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-08
Description

TMG partnered with UC Davis IEDO to launch the Aggie Venture Accelerator, supporting early-stage startups developing solutions at the intersection of life science, food and health. The program provides mentorship, structured programming, and up to $250,000 investment through the Aggie Venture Accelerator Fund managed by TMG. Based at Aggie Square, the accelerator leverages UC Davis's research strengths combined with TMG's scaling expertise.

2Novo Nordisk Foundation
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-27
Description

TMG has a unique partnership with the Novo Nordisk Foundation's BioInnovation Institute and its Planetary Health Alliance. The collaboration involves developing international leaders in food and planetary health through programs placing biotechnology-focused Ph.D. and postdoctoral students in cross-border exchange between Denmark and UC Davis.

marchgp.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Part of of TMG's partnership with the Novo Nordisk Foundation, BII supports TMG's ecosystem through the Planetary Health Alliance and collaborative projects in food security funded by the Bill and Melinda Gates Foundation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UC Davis-based institute leveraging expertise in food systems research and sustainability. TMG participates in IIFH Partner Summit events and collaborates on fellowship programs developing future food and health leaders.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

TMG maintains a strategic partnership with HKUST as part of its global ecosystem connections for innovation and technology development.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as part of TMG's ecosystem network of strategic global partners and uncommon collaborations.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as part of TMG's ecosystem network of strategic partners.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company Digestiva entered into an exclusive manufacturing partnership with Magdalena, a global leader in sugar cane processing, to enable scale-up production of enzymes for commercial milestones.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

S2G Ventures is one of the most prominent food, agriculture, and ocean technology venture capital firms, investing across the alternative protein, cellular agriculture, and food tech stack. It is a direct thematic peer to TMG, both targeting category-defining companies in food and health, though at materially larger fund scale.

2Big Idea Ventures
TypeDirect peer
Description

Big Idea Ventures runs the ProVeg Incubator and alternative protein-focused VC funds globally. It is a direct peer in food-tech and alternative protein VC, with a comparable accelerator-plus-fund structure similar to TMG's Aggie Venture Accelerator + March EXP model.

TypeDirect peer
Description

CPT Capital (formerly Cultivian Sandbox) invests across the food and agriculture value chain, including alternative proteins, agtech, and food biotech. It is a direct peer in early-stage food-tech and agtech VC with comparable check sizes and thematic depth.

TypeDirect peer
Description

Breakthrough Energy Ventures, founded by Bill Gates, invests in companies cutting greenhouse gas emissions across food, agriculture, energy, and industry. It is a direct thematic peer given its food-and-planetary-health focus and its affiliation with the same Gates ecosystem TMG advises.

TypeDirect peer
Description

IndieBio is the world's largest biotech accelerator, with programs in food biotech, climate, and human health. It is a direct peer through its accelerator-plus-investment model and biology-centric thesis that overlaps with TMG's Digestiva, EvodiaBio, and Number 8 Bio portfolio bets.

TypeBroad incumbent
Description

ADM Ventures is the corporate venture arm of Archer Daniels Midland, investing in food-tech, agtech, and alternative proteins. It is a broad incumbent peer competing for similar deal flow in alternative protein and fermentation but operating as part of a much larger strategic platform.

TypeBroad incumbent
Description

Pappas Capital is a life sciences and biotech venture firm with deep academic and research institution relationships. It is a broad incumbent peer overlapping with TMG's life sciences/health investing focus, particularly university spinouts and translational research.

TypeEmerging player
Description

Plug and Play operates one of the world's largest startup accelerator platforms with vertical programs in food/retail, health, and brand & retail. It is an emerging-player peer through its accelerator-plus-corporate-partnership model that overlaps with TMG's ecosystem-driven sourcing.

TypeEmerging player
Description

SOSV runs multiple vertical-specific accelerator programs (including IndieBio, HAX, and dlab) with a focus on deep-tech, biotech, and food. It is an emerging-player peer through its accelerator-heavy model and life sciences vertical, comparable in structure to TMG's Aggie Accelerator.

TypeBroad incumbent
Description

Novo Holdings is the holding company of the Novo Nordisk Foundation and operates a Seed Investments team funding early-stage biotech, food-tech, and planetary health startups. It is a broad incumbent peer through its formal Novo Nordisk Foundation/BioInnovation Institute partnership with TMG, investing in overlapping categories.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment6 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The March Group

Venture Capital / Early-Stage Investment Managementmarchgp.com

The March Group is a thematic early-stage venture capital firm that invests in exponential technology platforms across Precision Nutrition, Intelligent Health, and Food & Medicine, serving portfolio companies through pre-seed (Aggie Venture Accelerator Fund) and flagship (March EXP) vehicles while anchored within the UC system and advising institutional partners such as the Gates Foundation.

What The March Group does

The March Group (legal entity: March Partners LLC, incorporated in Delaware) is a thematic early-stage venture capital firm founded in 2019 and headquartered in Sacramento and Davis, California, with a stated mission of identifying and scaling exponential technologies at the intersection of food, health, and life sciences. The firm structures its investing around three thematic verticals — Precision Nutrition, Intelligent Health, and Food & Medicine — and codifies an "AI-at-the-Center" thesis that links artificial intelligence to GLP-1-driven disruption of the food industry. TMG operates two principal fund vehicles: the Aggie Venture Accelerator Fund, a pre-seed vehicle targeting UC Davis and UC system spinouts (offering up to $250,000 per startup through the April 2026-launched Aggie Venture Accelerator), and March EXP, the flagship early-stage fund backing category leaders across the three verticals. The portfolio includes ZeroAvia (hydrogen-electric aviation), Meati Foods (mycelium protein), Rivalz (AI-powered nutrition), Digestiva (food biotech enzymes), Engage3 (retail price intelligence), EvodiaBio (precision fermentation aromas), Number 8 Bio (methane-reducing feed additives), and VinZymes.

The firm monetizes primarily through venture fund management — management fees and carried interest on portfolio exits — with a secondary revenue stream from strategic advisory services for institutional partners such as the Bill & Melinda Gates Foundation. TMG serves two customer layers: (1) portfolio companies, which receive capital, mentorship, structured programming through the Aggie Accelerator, and access to AI tooling via partner PIPA; and (2) institutional advisory clients, most notably the Gates Foundation's Accelerator team, which TMG supports on advanced technology integration into the global food system. Deal flow is sourced primarily through TMG's anchor partnership with the UC Davis Innovation and Economic Development Office, broader UC system access (~1,400+ UC-formed startups, 250+ UC-linked $1B+ companies), and a strategic global network that includes the Novo Nordisk Foundation's BioInnovation Institute, HKUST, Lawrence Livermore National Laboratory, and the National Academies. TMG is led by four partners — Founding Partner Dr. Harold Schmitz (former Chief Science Officer of Mars, Incorporated), Christopher Lai, Stephen Badger, and Dr. Tony Lau — and operates as an independent, privately-held firm with no parent company or disclosed institutional investors in the firm itself.

The March Group firmographics

Firmographics
Name
The March Group
Legal name
March Partners LLC
Website
https://marchgp.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
The March Group is a thematic early-stage venture capital firm that invests in exponential technology platforms across Precision Nutrition, Intelligent Health, and Food & Medicine, serving portfolio companies through pre-seed (Aggie Venture Accelerator Fund) and flagship (March EXP) vehicles while anchored within the UC system and advising institutional partners such as the Gates Foundation.
Ownership category
akta.pro rank

The March Group industry classification

Industry
Product category
Venture Capital / Early-Stage Investment Management
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYFSANAHAD
Corporate Accelerators & Startup Programs
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds

Keywords

  • Venture capital
  • Early-stage investing
  • Life sciences investment
  • Food tech venture
  • Thematic venture capital

Where The March Group is headquartered

Location

Headquarters

HQ city
Davis
HQ country
United States
HQ region
North America

Offices2 records

Markets served

The March Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Venture Capital Fund Management: TMG manages venture funds including the Aggie Venture Accelerator Fund (pre-seed investments) and March EXP (flagship early-stage venture fund). Revenue generated through management fees and carried interest on portfolio company exits.
  2. Strategic Advisory Services: TMG provides strategic advisory services to institutional partners such as the Bill & Melinda Gates Foundation, supporting their Accelerator team's initiatives focused on advanced technologies and global food system improvements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

The March Group product offering

Product offering

Core offering

The March Group is a thematic early-stage venture capital firm that invests in and supports exponential technology platforms at the intersection of food, health, and life sciences. The firm manages the Aggie Venture Accelerator Fund (pre-seed investments in UC Davis and UC system spinouts) and March EXP (flagship early-stage fund) targeting category leaders in Precision Nutrition, Intelligent Health, and Food & Medicine. TMG also provides strategic advisory services to institutional partners such as the Bill & Melinda Gates Foundation.

Product overview

The March Group (TMG) is a thematic early-stage venture capital firm that operates two primary investment vehicles: the Aggie Venture Accelerator Fund and March EXP. The Aggie Venture Accelerator Fund is a pre-seed fund focused on identifying spinouts and translational ventures from UC Davis and the UC system. March EXP is TMG's flagship early-stage venture fund targeting category leaders in Precision Nutrition, Intelligent Health, and Food & Medicine. TMG's portfolio includes investments in companies such as Engage3, Digestiva, Rivalz, ZeroAvia, VinZymes, EvodiaBio, Number8Bio, and Meati Foods.

Differentiator

Problem solved

Functional benefit

Products and services

  • Aggie Venture Accelerator Fund A pre-seed fund managed by The March Group that seeks to identify the best spinouts and translational ventures emerging from UC Davis and the broader UC system. It is part of the Aggie Venture Accelerator program offering mentorship, structured programming, and investment to early-stage startups at the intersection of life science, food, and health.
  • March EXP The flagship early-stage venture fund of The March Group that invests in category leaders emerging in Precision Nutrition, Intelligent Health, and Food & Medicine. Portfolio companies include ZeroAvia, Meati Foods, Rivalz, Digestiva, EvodiaBio, Number 8 Bio, Engage3, and VinZymes.

Quantifiable outcome

  • Over 300 UC Davis-supported startups have raised over $4 billion in funding over the past decade
  • +1 more outcomes

Companies that use The March Group

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles4 records

The March Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

The March Group partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • UC Davis Innovation and Economic Development OfficecoreStrategic or Co-development Partner · 8 April 2026TMG partnered with UC Davis IEDO to launch the Aggie Venture Accelerator, supporting early-stage startups developing solutions at the intersection of life science, food and health. The program provides mentorship, structured programming, and up to $250,000 investment through the Aggie Venture Accelerator Fund managed by TMG. Based at Aggie Square, the accelerator leverages UC Davis's research strengths combined with TMG's scaling expertise.
  • Novo Nordisk FoundationcoreStrategic or Co-development Partner · 27 March 2025TMG has a unique partnership with the Novo Nordisk Foundation's BioInnovation Institute and its Planetary Health Alliance. The collaboration involves developing international leaders in food and planetary health through programs placing biotechnology-focused Ph.D. and postdoctoral students in cross-border exchange between Denmark and UC Davis.
  • BioInnovation Institute (BII)coreStrategic or Co-development PartnerPart of of TMG's partnership with the Novo Nordisk Foundation, BII supports TMG's ecosystem through the Planetary Health Alliance and collaborative projects in food security funded by the Bill and Melinda Gates Foundation.
  • Innovation Institute for Food and Health (IIFH)coreStrategic or Co-development PartnerUC Davis-based institute leveraging expertise in food systems research and sustainability. TMG participates in IIFH Partner Summit events and collaborates on fellowship programs developing future food and health leaders.
  • Hong Kong University of Science and Technology (HKUST)minorStrategic or Co-development PartnerTMG maintains a strategic partnership with HKUST as part of its global ecosystem connections for innovation and technology development.
  • Lawrence Livermore National Laboratory (LLNL)minorStrategic or Co-development PartnerListed as part of TMG's ecosystem network of strategic global partners and uncommon collaborations.
  • National AcademiesminorStrategic or Co-development PartnerListed as part of TMG's ecosystem network of strategic partners.
  • MagdalenaminorStrategic or Co-development PartnerPortfolio company Digestiva entered into an exclusive manufacturing partnership with Magdalena, a global leader in sugar cane processing, to enable scale-up production of enzymes for commercial milestones.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

The March Group competitors and assessment

Company assessment

Direct peers

  • S2G Ventures: S2G Ventures is one of the most prominent food, agriculture, and ocean technology venture capital firms, investing across the alternative protein, cellular agriculture, and food tech stack. It is a direct thematic peer to TMG, both targeting category-defining companies in food and health, though at materially larger fund scale.
  • Big Idea Ventures: Big Idea Ventures runs the ProVeg Incubator and alternative protein-focused VC funds globally. It is a direct peer in food-tech and alternative protein VC, with a comparable accelerator-plus-fund structure similar to TMG's Aggie Venture Accelerator + March EXP model.
  • CPT Capital: CPT Capital (formerly Cultivian Sandbox) invests across the food and agriculture value chain, including alternative proteins, agtech, and food biotech. It is a direct peer in early-stage food-tech and agtech VC with comparable check sizes and thematic depth.
  • Breakthrough Energy Ventures: Breakthrough Energy Ventures, founded by Bill Gates, invests in companies cutting greenhouse gas emissions across food, agriculture, energy, and industry. It is a direct thematic peer given its food-and-planetary-health focus and its affiliation with the same Gates ecosystem TMG advises.
  • IndieBio: IndieBio is the world's largest biotech accelerator, with programs in food biotech, climate, and human health. It is a direct peer through its accelerator-plus-investment model and biology-centric thesis that overlaps with TMG's Digestiva, EvodiaBio, and Number 8 Bio portfolio bets.

Broad incumbents

  • ADM Ventures: ADM Ventures is the corporate venture arm of Archer Daniels Midland, investing in food-tech, agtech, and alternative proteins. It is a broad incumbent peer competing for similar deal flow in alternative protein and fermentation but operating as part of a much larger strategic platform.
  • Pappas Capital: Pappas Capital is a life sciences and biotech venture firm with deep academic and research institution relationships. It is a broad incumbent peer overlapping with TMG's life sciences/health investing focus, particularly university spinouts and translational research.
  • Novo Holdings (Seed Investments team): Novo Holdings is the holding company of the Novo Nordisk Foundation and operates a Seed Investments team funding early-stage biotech, food-tech, and planetary health startups. It is a broad incumbent peer through its formal Novo Nordisk Foundation/BioInnovation Institute partnership with TMG, investing in overlapping categories.

Emerging players

  • Plug and Play Tech Center: Plug and Play operates one of the world's largest startup accelerator platforms with vertical programs in food/retail, health, and brand & retail. It is an emerging-player peer through its accelerator-plus-corporate-partnership model that overlaps with TMG's ecosystem-driven sourcing.
  • SOSV: SOSV runs multiple vertical-specific accelerator programs (including IndieBio, HAX, and dlab) with a focus on deep-tech, biotech, and food. It is an emerging-player peer through its accelerator-heavy model and life sciences vertical, comparable in structure to TMG's Aggie Accelerator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

The March Group social profiles

Digital presence

The March Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The March Group leadership team

Management profile

Number of profiles

Profiles4 records

The March Group subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

The March Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The March Group M&A and investment

M&A and investment

M&A

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The March Group

What does The March Group do?

The March Group is a thematic early-stage venture capital firm that invests in and supports exponential technology platforms at the intersection of food, health, and life sciences. The firm manages the Aggie Venture Accelerator Fund (pre-seed investments in UC Davis and UC system spinouts) and March EXP (flagship early-stage fund) targeting category leaders in Precision Nutrition, Intelligent Health, and Food & Medicine. TMG also provides strategic advisory services to institutional partners such as the Bill & Melinda Gates Foundation.

Is The March Group a public or private company?

The March Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was The March Group founded?

The March Group was founded in 2018. It employs 11 to 50 people.

Where is The March Group based?

The March Group is headquartered in Davis, United States, in the North America region.

How does The March Group make money?

Two revenue lines are on record. Venture Capital Fund Management is the primary driver. The others are strategic Advisory Services.

Who are The March Group's main competitors?

Direct peers on record are S2G Ventures, Big Idea Ventures, CPT Capital, Breakthrough Energy Ventures and IndieBio. Broad incumbents are ADM Ventures, Pappas Capital and Novo Holdings (Seed Investments team). Emerging players are Plug and Play Tech Center and SOSV.

Does The March Group have an API?

No public API is recorded for The March Group.

What industry is The March Group in?

The March Group's product category is Venture Capital / Early-Stage Investment Management. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAAAM, Accelerators & Incubators (Investor-Operated). Its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
UC Davis College of Biological SciencesAggie Venture Accelerator Welcomes Inaugural Cohort of Life Science StartupsThe University of California, Davis Innovation and Economic Development Office has announced the inaugural cohort of the Aggie Venture Accelerator, selecting three life science startups: SinewUS, Pharm to Food, and ThriveSpan Labs. Delivered in partnership with The March Group, the four-month accelerator program provides intensive mentorship, entrepreneurial training, and strategic industry connections, concluding with a Demo Day for startups to present to venture capital firms and angel investors. The launch marks a milestone in UC Davis' ongoing investment in innovation and entrepreneurship, aiming to bridge the gap between scientific discovery and commercialization.Global VenturingUS university UC Davis ropes in venture capital to boost spinouts -UC Davis university is launching a series of sector-specific spinout funds, starting with a $25 million healthcare-focused fund, to finance startups emerging from its research labs and reduce reliance on declining federal research funding. The university has partnered with venture capital firms including HM Ventures and The March Group, and is in talks with other VCs and corporate investors, marking a strategic shift from its historical focus on licensing technologies to taking equity stakes in spinout companies. UC Davis is also opening a 1.2 million square foot innovation park called Aggie Square, which includes a bio-pharma accelerator for South Korean startups seeking US market entry.UC Davis College of Biological SciencesData-Driven Insights in the Food and Health Biotech Startup EcosystemMichael Russelle Alvarez completed a venture capital fellowship with The March Group (TMG), applying his expertise in analytical chemistry and bioinformatics to support food and health biotech startups. During this period, he conducted technical due diligence on potential investments and provided specialized analytics services to portfolio companies including Digestiva, Biorbis, PIPA, and WellVine/Sonomaceuticals.American City Business JournalsRivalz, Davis nutritional snack company, raises $6.1 millionRivalz Snacks raised $6.1 million in venture capital funding led by The March Group, bringing total funding to $8.4 million since 2022. The company plans to expand production, sales, and marketing of nutritional salty snacks, with revenue on track to reach $1 million in its first year.